FIELD: medicine, pharmaceutics.
SUBSTANCE: there is offered a neuroprotective agent. The agent represents 4-methyl-2,6-diisobornylphenol formerly known for its antiplatelet and antithrombogenic action.
EFFECT: means prevents transient cerebral ischemia death, reduces a degree of post-ischemic neurological deficiency.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
| DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
| NEUROPROTECTIVE MEANS, HAVING THE PROPERTIES OF ANTIOXIDANT AND NITRIC OXIDE DONATOR | 2016 |
|
RU2680526C1 |
| AGENT RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2020 |
|
RU2740895C1 |
| MEDICATION INCREASING BRAIN BLOOD FLOW | 2007 |
|
RU2351321C1 |
| METHOD FOR SIMULATING GLOBAL CEREBRAL ISCHEMIA IN RATS | 2014 |
|
RU2544369C1 |
| ANTI-ISCHEMIC DRUG | 2012 |
|
RU2499593C1 |
| RETINOPROTECTOR | 2009 |
|
RU2406487C1 |
| AGENT WITH NEUROPROTECTIVE ACTIVITY | 2019 |
|
RU2800955C2 |
| AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
Authors
Dates
2010-12-20—Published
2009-04-20—Filed